Use of Discharge Disposition to Determine Stroke Severity After TAVR
Circulation: Cardiovascular Interventions · 2024
DOI: 10.1161/circinterventions.123.013698 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation: Cardiovascular Interventions, 2024. Verfasst von Neel M Butala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Rocky Mountain Regional VA Medical Center, Aurora, CO (N.M.B.). Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Patient Discharge, Severity of Illness Index, Aortic Valve Stenosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Themen: Schlaganfall
Abstract (Originalsprache)
transcatheter aortic valve replacement; stroke Despite reductions in procedure-related mortality and complications, 1 stroke remains a persistent complication after transcatheter aortic valve replacement (TAVR).However, only disabling strokes are associated with increased mortality post-TAVR, whereas nondisabling strokes are not. 2 Consequently, only disabling stroke has been included in the composite endpoint for recent TAVR clinical trials.The distinction between disabling and non-disabling stroke post-TAVR is further highlighted by the PROTECTED-TAVR trial, which demonstrated a potential benefit of cerebral embolic protection on disabling stroke but not for the primary endpoint of any stroke.3 Given these differences in outcomes and preventive strategies, it is important to understand the severity of post-TAVR strokes that occur in clinical practice.While formal neurologic adjudication is frequently used in clinical trials, this approach is impractical outside of the trial setting.The TVT registry only captures stroke in aggregate, administrative claims do not specify functional status after stroke, and attempts to collect more detailed information on stroke severity in other national registries have been unsuccessful owing to frequent missing data.As such, it is challenging to distinguish between disabling and non-disabling strokes after TAVR using real-world data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Rocky Mountain Regional VA Medical Center, Aurora, CO (N.M.B.).
- Division of Cardiology, University of Colorado School of Medicine, Aurora (N.M.B.).
- Cleveland Clinic Foundation, OH (S.R.K.).
- Division of Cardiovascular Medicine, Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.).
- Cardiovascular Research Foundation, New York, NY (D.J.C.).
- St. Francis Hospital and Heart Center, Roslyn, NY (D.J.C.).
ORCID-Profile: Neel M Butala, Samir R Kapadia, Robert W Yeh, David J Cohen
Förderung
- NHLBI NIH HHS
Zitieren
APA
Butala, N. M., Kapadia, S. R., Yeh, R. W., & Cohen, D. J. (2024). Use of Discharge Disposition to Determine Stroke Severity After TAVR. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.123.013698
Vancouver
Butala NM, Kapadia SR, Yeh RW, Cohen DJ. Use of Discharge Disposition to Determine Stroke Severity After TAVR. Circulation: Cardiovascular Interventions. 2024. doi:10.1161/circinterventions.123.013698
BibTeX
@article{Butala2024,
author = {Butala, Neel M and Kapadia, Samir R and Yeh, Robert W and Cohen, David J},
title = {Use of Discharge Disposition to Determine Stroke Severity After TAVR},
journal = {Circulation: Cardiovascular Interventions},
year = {2024},
doi = {10.1161/circinterventions.123.013698}
}
EUVIMED